Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

A comparative, population-based analysis of pituitary incidentalomas vs clinically manifesting sellar masses.

Vaninetti NM, Clarke DB, Zwicker DA, Yip CE, Tugwell B, Doucette S, Theriault C, Aldahmani K, Imran SA.

Endocr Connect. 2018 May;7(5):768-776. doi: 10.1530/EC-18-0065. Epub 2018 Apr 30.

2.

Diabetes-Related Behavior Change Knowledge Transfer to Primary Care Practitioners and Patients: Implementation and Evaluation of a Digital Health Platform.

Abidi S, Vallis M, Piccinini-Vallis H, Imran SA, Abidi SSR.

JMIR Med Inform. 2018 Apr 18;6(2):e25. doi: 10.2196/medinform.9629.

3.

Targets for Glycemic Control.

Diabetes Canada Clinical Practice Guidelines Expert Committee, Imran SA, Agarwal G, Bajaj HS, Ross S.

Can J Diabetes. 2018 Apr;42 Suppl 1:S42-S46. doi: 10.1016/j.jcjd.2017.10.030. No abstract available.

PMID:
29650110
4.

Reflex and reflective testing strategies for early detection of pituitary dysfunction.

Elnenaei M, Minney D, Clarke DB, Kumar-Misir A, Imran SA.

Clin Biochem. 2018 Apr;54:78-84. doi: 10.1016/j.clinbiochem.2018.02.014. Epub 2018 Feb 24.

PMID:
29486187
5.

Unusual AIP mutation and phenocopy in the family of a young patient with acromegalic gigantism.

Imran SA, Aldahmani KA, Penney L, Croul SE, Clarke DB, Collier DM, Iacovazzo D, Korbonits M.

Endocrinol Diabetes Metab Case Rep. 2018 Feb 9;2018. pii: 17-0092. doi: 10.1530/EDM-17-0092. eCollection 2018.

6.

The effect of time of day testing and utility of 30 and 60 minute cortisol values in the 250 mcg ACTH stimulation test.

Munro V, Elnenaei M, Doucette S, Clarke DB, Imran SA.

Clin Biochem. 2018 Apr;54:37-41. doi: 10.1016/j.clinbiochem.2018.02.010. Epub 2018 Feb 16.

PMID:
29458002
7.

Thyrotoxicosis Associated with a Hypopharyngeal Toxic Nodular Thyroid.

Imran SA, Hinchey A, Hart R, Bullock M, Ross A, Burrell S.

Case Rep Endocrinol. 2017;2017:5128563. doi: 10.1155/2017/5128563. Epub 2017 Nov 2.

8.

Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.

Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L, Roughton M, Ravichandran S, Petersenn S, Biller BMK, Newell-Price J; Pasireotide G2304 Study Group.

Lancet Diabetes Endocrinol. 2018 Jan;6(1):17-26. doi: 10.1016/S2213-8587(17)30326-1. Epub 2017 Oct 12. Erratum in: Lancet Diabetes Endocrinol. 2018 Jan;6(1):e1.

PMID:
29032078
9.

Radiological Growth Patterns of Prolactinomas and Nonfunctioning Adenomas.

Imran SA, Shankar J, Hebb ALO, Croul SE, Clarke DB.

Can J Neurol Sci. 2017 Sep;44(5):508-513. doi: 10.1017/cjn.2017.203. Epub 2017 Jul 3.

PMID:
28669359
10.

Letter to the Editor: Hypothalamic Kisspeptin in Female Rat Models of PCOS.

Wilkinson M, Brown RE, Imran SA, Wilkinson DA.

Endocrinology. 2017 Jun 1;158(6):2011. doi: 10.1210/en.2017-00327. No abstract available.

PMID:
28575428
11.

A Digital Framework to Support Providers and Patients in Diabetes Related Behavior Modification.

Abidi S, Vallis M, Piccinini-Vallis H, Imran SA, Abidi SSR.

Stud Health Technol Inform. 2017;235:589-593.

PMID:
28423861
12.

Visualization of 90Yttrium Colloid Within a Cystic Craniopharyngioma Using PET/CT/MRI Fusion.

Burrell S, Hebb AL, Imran SA, Mishra A, Mawko G, Clarke DB.

Can J Neurol Sci. 2017 Mar;44(2):192-193. doi: 10.1017/cjn.2016.410. Epub 2016 Nov 16. No abstract available.

PMID:
27846921
13.

Analysis and natural history of pituitary incidentalomas.

Imran SA, Yip CE, Papneja N, Aldahmani K, Mohammad S, Imran F, Zwicker DA, Theriault C, Thompson K, Clarke DB, Van Uum S.

Eur J Endocrinol. 2016 Jul;175(1):1-9. doi: 10.1530/EJE-16-0041. Epub 2016 Apr 1.

14.

Recovery of adrenal function after chronic secondary adrenal insufficiency in patients with hypopituitarism.

Munro V, Tugwell B, Doucette S, Clarke DB, Lacroix A, Imran SA.

Clin Endocrinol (Oxf). 2016 Aug;85(2):216-22. doi: 10.1111/cen.13048. Epub 2016 Mar 21.

PMID:
26928716
15.

Thyroid hormone (levothyroxine) replacement via the respiratory route by inhalation: in vitro exploratory studies.

Agu RU, Mactavish J, K Yeung P, Imran SA.

Expert Opin Drug Deliv. 2016;13(2):195-205. doi: 10.1517/17425247.2016.1115012. Epub 2015 Dec 18.

PMID:
26684066
16.

Morphometric changes correlate with poor psychological outcomes in patients with acromegaly.

Imran SA, Tiemensma J, Kaiser SM, Vallis M, Doucette S, Abidi E, Yip CE, De Tugwell B, Siddiqi F, Clarke DB.

Eur J Endocrinol. 2016 Jan;174(1):41-50. doi: 10.1530/EJE-15-0888.

17.

Sellar Masses: An Epidemiological Study.

Al-Dahmani K, Mohammad S, Imran F, Theriault C, Doucette S, Zwicker D, Yip CE, Clarke DB, Imran SA.

Can J Neurol Sci. 2016 Mar;43(2):291-7. doi: 10.1017/cjn.2015.301. Epub 2015 Nov 2.

PMID:
26522017
18.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators.

N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.

19.

Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial.

Schopohl J, Gu F, Rubens R, Van Gaal L, Bertherat J, Ligueros-Saylan M, Trovato A, Hughes G, Salgado LR, Boscaro M, Pivonello R; Pasireotide B2305 Study Group.

Pituitary. 2015 Oct;18(5):604-12. doi: 10.1007/s11102-014-0618-1.

20.

D-WISE: Diabetes Web-Centric Information and Support Environment: conceptual specification and proposed evaluation.

Abidi S, Vallis M, Raza Abidi SS, Piccinini-Vallis H, Imran SA.

Can J Diabetes. 2014 Jun;38(3):205-11. doi: 10.1016/j.jcjd.2014.03.006.

Supplemental Content

Loading ...
Support Center